PDL BIOPHARMA, INC.·4

Apr 7, 8:48 AM ET

Stone Christopher Lewis 4

4 · PDL BIOPHARMA, INC. · Filed Apr 7, 2020

Insider Transaction Report

Form 4
Period: 2019-12-12
Stone Christopher Lewis
VP and General Counsel
Transactions
  • Tax Payment

    Common stock

    2019-12-12$3.43/sh1,240$4,253619,789 total
  • Tax Payment

    Common stock

    2019-12-16$3.33/sh2,686$8,944617,103 total

Documents

1 file
  • 4
    wf-form4_158626367081260.xmlPrimary

    FORM 4